Urine drug monitoring (UDM) is conducted to support safe, effective clinical care, monitor adherence to prescribed medications, detect illicit or non-prescribed substance use, meet judicial and partner requirements, and promote accountability and recovery stability.

All testing must be ordered by a licensed provider and used to guide treatment planning, medication adjustments, and risk monitoring. Results are reviewed and interpreted by a qualified provider in accordance with medical necessity requirements.

Testing may be required for probation, parole, court-ordered monitoring, or DHS involvement. AWR follows all partner-specific testing frequencies, documentation standards, and reporting timelines.

Testing supports safe environments within sober living homes, reinforces medication and program compliance, and allows early intervention when relapse risk is identified.

Clients will complete identity verification, provide an observed urine sample and have the specimen labeled and documented before being processed for screening or confirmation testing.

Point-of-care (POC) testing is performed using CLIA-waived devices to provide rapid, preliminary results for immediate clinical or compliance decisions. Results are presumptive and may require confirmation.

Specimens are sent to a CLIA-certified laboratory for definitive testing using advanced methods. These results are legally defensible and used for final clinical and judicial decisions.

Chain-of-custody procedures ensure proper identification, documentation, and secure transfer of specimens. Required elements include patient identification, date and time of collection, collector signature, and tracking of all transfers.

Results may be negative, positive, or inconclusive. All results are reviewed by a licensed trained provider and shared in accordance with HIPAA and applicable partner agreements.

Specimens must be labeled immediately, stored securely, and transported promptly to prevent contamination, tampering, or misidentification.

All specimens must be logged accurately, matched to the correct client and provider order, and included in batch documentation with proper chain-of-custody.

Specimens must be prepared for scheduled courier pick-up and stored securely until transport to maintain integrity and accuracy of results.

Staff must be notified immediately if there are issues such as inability to collect a sample, suspected tampering, refusal to test, labeling errors, broken chain-of-custody, or equipment malfunction.